Organ transplant recipients regularly receive immunosuppressive drugs to help minimize the risk of rejection, but those drugs come with significant risks of their own, including leaving patients open to predatory infections and even certain...
Donor-transmitted disease in organ transplantation is uncommon, but possible. The LDL receptor, a key regulator of lipoprotein metabolism, is abundant in the liver. Mutations in the LDLR gene, leading to...
The ASTS Foundation Fund the Future Campaign has a goal of raising $100,000 to fund research grants. We need your help! Please consider donating any amount.
Have you gotten your copy of the ASTS 40th anniversary book yet? One free copy is available to ASTS members, and non-members can purchase a copy in the ASTS Store.
ASTS, along with the American Hepato-Pancreato-Biliary Association and the Society of Surgical Oncology, will hold a consensus conference on Training in HBP Surgery Oct. 27, 2014, at the Omni San Francisco.
There are complex risk-benefit tradeoffs with different transplantation strategies for end-stage liver disease patients on renal support. Using a Markov discrete-time state transition model, scientists...
Uric acid is associated with increased mortality in kidney transplant recipients, but it is uncertain if this involves endothelial dysfunction. We hypothesized, first, that there was an association between uric acid and endothelial...
Subscribe to ASTS NewsBrief
|State / Province:|
|Are you a member of ASTS?||Yes No|